1,3-Benzodioxolylbutanamine

From Food & Medicine Encyclopedia

(Redirected from Benzodioxolylbutanamine)

BDB.svg
1,3-Benzodioxolylbutanamine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


1,3-Benzodioxolylbutanamine (also known as BDB) is a chemical compound of the substituted amphetamines class. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known psychoactive substances.

Chemical Structure and Properties[edit]

1,3-Benzodioxolylbutanamine has a chemical structure that includes a benzodioxole ring attached to a butanamine chain. The IUPAC name for BDB is 1-(1,3-Benzodioxol-5-yl)butan-2-amine. The molecular formula is C11H15N1O2.

Pharmacology[edit]

BDB acts as a serotonin and dopamine releasing agent. It is known to produce effects similar to those of MDMA, including euphoria, increased empathy, and enhanced sensory perception. However, the potency and duration of BDB's effects are generally considered to be less intense compared to MDMA.

Legal Status[edit]

The legal status of BDB varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to MDMA and MDA, which are often regulated under drug control laws.

Related Compounds[edit]

See Also[edit]

References[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.